Overview
Palo Santo is a Chicago-based venture fund focused on investing in next-generation neuroscience companies developing breakthrough therapeutics and technologies for mental health. The firm targets early-stage opportunities, including pre-seed, seed, and Series A rounds, with a particular emphasis on psychedelic medicines and therapies to address the global mental health crisis, making it highly relevant to preventive health.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.